Condition
Organ or Tissue Transplant; Complications
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Unknown1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07394660Not ApplicableCompletedPrimary
The Effect of Remote Reiki Treatment on Hopelessness, Fatigue and Pain in Patients Awaiting Organ Transplantation
NCT03806764Not ApplicableUnknown
Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient
NCT01525329Phase 3Terminated
Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease
NCT02500212Phase 4CompletedPrimary
Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients
NCT02219269Completed
A Complex Contraception Registry
Showing all 5 trials